List of works by Judy Dering

A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer

scientific article

AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53.

scientific article published on 5 October 2013

Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer

scientific article published on March 2013

Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target

scientific article published in October 2008

Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer

scientific article

Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro

scientific article published on February 2007

ERCC5 is a novel biomarker of ovarian cancer prognosis

scientific article

Estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2), and epidermal growth factor receptor expression and benefit from lapatinib in a randomized trial of paclitaxel with lapatinib or placebo as first-line treatme

scientific article

Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer

scientific article

HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells

scientific article

Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines

scientific article

In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of response

scientific article

Knockdown of ovarian cancer amplification target ADRM1 leads to downregulation of GIPC1 and upregulation of RECK.

scientific article published on 22 March 2011

Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures

scientific article published on April 2016

Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitro

scientific article

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

scientific article

POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer

scientific article published on 22 December 2013

Periostin promotes ovarian cancer angiogenesis and metastasis

scientific article published on 4 August 2010

Pharmacodynamic Characterization of the Efficacy Signals Due to Selective BRAF Inhibition with PLX4032 in Malignant Melanoma ⬇️

scientific article published on August 1, 2010

Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer

scientific article published on 27 October 2008

Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer

scientific article

Recent translational research: microarray expression profiling of breast cancer--beyond classification and prognostic markers?

scientific article

The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth

scientific article published on 14 March 2013

Therapeutic potential of the poly(ADP-ribose) polymerase inhibitor rucaparib for the treatment of sporadic human ovarian cancer

scientific article published on 31 May 2013

Paulina is supported by:

About Paulina

Help